About Advances in Cancer Immunotherapy

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these six-hour programs will facilitate understanding of:

The rationale for common approaches to immunotherapy
The clinical applications of immunotherapy for disease states with FDA-approved treatments (melanoma, and lung, genitourinary, hematologic, and head and neck cancers)
Operational and reimbursement barriers to implementing immunotherapy in a community setting and strategies to overcome them
The identification and management of immune-related adverse events from the nursing and prescriber perspective in the clinic and emergency settings